Health & Fitness
Fri, June 8, 2012Thu, June 7, 2012Wed, June 6, 2012Tue, June 5, 2012Mon, June 4, 2012Sat, June 2, 2012Fri, June 1, 2012Thu, May 31, 2012Wed, May 30, 2012Tue, May 29, 2012Mon, May 28, 2012Sun, May 27, 2012Sat, May 26, 2012Fri, May 25, 2012Thu, May 24, 2012A Forward Look, the Year Ahead -- Featured Research on Cadence Pharmaceuticals, Inc. and Activision Blizzard, Inc.
Published in Health and Fitness on Thursday, May 31st 2012 at 6:25 GMT by Market Wire
May 31, 2012 09:11 ET
A Forward Look, the Year Ahead -- Featured Research on Cadence Pharmaceuticals, Inc. and Activision Blizzard, Inc.
HONG KONG--(Marketwire - May 31, 2012) - Today, [ www.BollingerReport.com ] introduced featured coverage of Cadence Pharmaceuticals, Inc. (
With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Bollinger Report screened and selected Cadence Pharmaceuticals, Inc. for its current position within the healthcare industry. Cadence Pharmaceuticals, Inc. (Cadence) is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing products principally for use in the hospital setting. The Company has rights to one product, OFIRMEV (acetaminophen) injection, an intravenous (IV), formulation of acetaminophen. A copy of this report featuring Cadence Pharmaceuticals, Inc. (
Bollinger Report is featuring Activision Blizzard, Inc. for its changing role within the technology industry. Activision, Inc. (Activision Blizzard) is a worldwide publisher of online, personal computer (PC), console, handheld, and mobile interactive entertainment products. The Company operates in three segments: Activision Publishing, Inc. To download researches and analysis on Activision Blizzard, Inc. (
About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community. John Bollinger and BollingerBands.com are not affiliated with BollingerReport.com and do not endorse the service or any of the recommendations made by the service.
